Citius Pharma (NASDAQ:CTXR) just reported results for the second quarter of 2024. Citius Pharma reported earnings per share of -5 cents. This met the analyst estimate for EPS of -5 cents. The company did not report any revenue for the quarter. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. ...